Effects of pharmacist outpatient interventions on adults with diabetes mellitus: A systematic review

Pharmacotherapy

Volumn 28, Issue 4, 2008, Pages 421-436

  Wubben, Deborah P ^a   Vivian, Eva M ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Case management; Diabetes mellitus; Pharmacy practice

Indexed keywords

HEMOGLOBIN A1C;

COST EFFECTIVENESS ANALYSIS; DATA SYNTHESIS; DIABETES MELLITUS; GLYCEMIC CONTROL; HEALTH CARE COST; HEALTH SERVICE; HUMAN; INFORMATION PROCESSING; INSULIN DEPENDENT DIABETES MELLITUS; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; OUTPATIENT CARE; PATIENT CARE; PATIENT EDUCATION; PHARMACIST; PRESCRIPTION; REVIEW; SELF CARE; SYSTEMATIC REVIEW; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; CONTROLLED CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS; DISEASE MANAGEMENT; HUMANS; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PHARMACEUTICAL SERVICES; PHARMACISTS; PROFESSIONAL ROLE; QUALITY ASSURANCE, HEALTH CARE;

EID: 41549130374     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.28.4.421     Document Type: Review

References (67)

1. Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2005. Available from http://www.cdc.gov/diabetes/pubs/estimates05. htm#prev. Accessed August 7, 2006.
2. Renders CM, Valk GD, Griffin S, Wagner EH, Eijk JT, Assendelft WJ. Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings. Cochrane Database Syst Rev 2001;(1):CD001481.
3. American Diabetes Association. Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care 1998;21:296-309.
4. Hogan P, Dall T, Nikolov P, for the American Diabetes Association. Economic costs of diabetes in the U.S. in 2002. Diabetes Care 2003;26:917-32.
5. Norris SL, Nichols PJ, Caspersen CJ, et al. The effectiveness of disease and case management for people with diabetes: a systematic review. Am J Prev Med 2002;22(suppl 4):15-38.
6. Centers for Disease Control and Prevention. Data and trends. National diabetes surveillance system. Preventive care practices. Available from http://www.cdc.gov/diabetes/statistics/preventive/fAllPractices.htm. Accessed August 7, 2006.
7. Schachter KA, Cohen SJ. From research to practice: challenges to implementing national diabetes guidelines with five community health centers on the U.S.-Mexico border [online exclusive article]. Prev Chronic Dis 2005;2:A17. Available from http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 1323320.
8. Task Force on Community Preventive Services. Recommendations for healthcare system and self-management education interventions to reduce morbidity and mortality from diabetes. Am J Prev Med 2002;22(suppl 4):10-14.
9. Deakin T, McShane CE, Cade JE, Williams RD. Group-based training for self-management strategies in people with type 2 diabetes mellitus. Cochrane Database Syst Rev 2005;(2):CD003417.
10. Ellis SE, Speroff T, Dittus RS, Brown A, Pichert JW, Elasy TA. Diabetes patient education: a meta-analysis and meta-regression. Patient Educ Couns 2004;52:97-105.
11. Gary TL, Genkinger JM, Guallar E, Peyrot M, Brancati FL. Meta-analysis of randomized educational and behavioral interventions in type 2 diabetes. Diabetes Educ 2003;29:488-501.
12. Mensing C, Boucher J, Cypress M, et al. National standards for diabetes self-management education. Diabetes Care 2006;29(suppl 1):S78-85.
13. Norris SL, Lau J, Smith SJ, Schmid CH, Engelgau MM. Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care 2002;25:1159-71.
14. Sarkisian CA, Brown AF, Norris KC, Wintz RL, Mangione CM. A systematic review of diabetes self-care interventions for older, African-American, or Latino adults. Diabetes Educ 2003;29:467-79.
15. Vermeire E, Wens J, Van Royen P, Biot Y, Hearnshaw H, Lindenmeyer A. Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus. Cochrane Database Syst Rev 2005;(2):CD003638.
16. Warsi A, Wang PS, LaValley MP, Avorn J, Solomon DH. Self-management education programs in chronic disease: a systematic review and methodological critique of the literature. Arch Intern Med 2004;164:1641-9.
17. Ferguson JA, Weinberger M. Case management programs in primary care. J Gen Intern Med 1998;13:123-6.
18. Loveman E, Royle P, Waugh N. Specialist nurses in diabetes mellitus. Cochrane Database Syst Rev 2003;(2):CD003286.
19. Norris SL, Chowdhury FM, Van Le K, et al. Effectiveness of community health workers in the care of persons with diabetes. Diabet Med 2006;23:544-56.
20. Shojania KG, Ranji SR, McDonald KM, et al. Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis. JAMA 2006;296:427-40.
21. Knapp KK, Paavola FG, Maine LL, Sorofman B, Politzer RM. Availability of primary care providers and pharmacists in the United States. J Am Pharm Assoc (Wash) 1999;39:127-35.
22. Harris MI. Medical care for patients with diabetes: epidemiologic aspects. Ann Intern Med 1996;124(1 pt 2):117-22.
23. Kroon LA, Coleman LT, Koda-Kimble MA. The management of type 2 diabetes mellitus: a call to action for pharmacists. US Pharm 1997;May(suppl 1):1-18.
24. Davis ED. Role of the diabetes nurse educator in improving patient education. Diabetes Educ 1990;16:36-8.
25. Feddersen E, Lockwood DH. An inpatient diabetes educator's impact on length of hospital stay. Diabetes Educ 1994;20:125-8.
26. Koproski J, Pretto Z, Poretsky L. Effects of an intervention by a diabetes team in hospitalized patients with diabetes. Diabetes Care 1997;20:1553-5.
27. Weinberger M, Kirkman MS, Samsa GP, et al. A nurse-coordinated intervention for primary care patients with non-insulin-dependent diabetes mellitus: impact on glycemic control and health-related quality of life. J Gen Intern Med 1995;10:59-66.
28. Baran RW, Crumlish K, Patterson H, et al. Improving outcomes of community-dwelling older patients with diabetes through pharmacist counseling. Am J Health-Syst Pharm 1999;56:1535-9.
29. Coast-Senior EA, Kroner BA, Kelley CL, Trilli LE. Management of patients with type 2 diabetes by pharmacists in primary care clinics. Ann Pharmacother 1998;32:636-41.
30. Cranor CW, Bunting BA, Christensen DB. The Asheville project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash) 2003;43:173-84.
31. Huff PS, Ives TJ, Almond SN, Griffin NW. Pharmacist-managed diabetes education service. Am J Hosp Pharm 1983;40:991-4.
32. Funnell MM, Brown TL, Childs BP, et al. National standards for diabetes self-management education. Diabetes Educ 2007;33:599-614.
33. Shojania K, McDonald K, Wachter R, Owens D. Closing the quality gap: a critical analysis of quality improvement strategies. Vol 1. Series overview and methodology. Technical review 9 (contract no. 290-02-0017 to the Stanford University-UCSF evidence-based practices center). AHRQ publication no. 04-0051-1. Available from http://www.ahrq.gov/downloads/pub/evidence/pdf/ qualgap1/qualgap1.pdf. Accessed August 14, 2006.
34. Cochrane Effective Practice and Organization of Care Review Group. The data collection checklist. Available from http://www.epoc.uottawa.ca/ checklist2002.doc. Accessed December 4, 2006.
35. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998;52:377-84.
36. Rothman RL, So SA, Shin J, et al. Labor characteristics and program costs of a successful diabetes disease management program. Am J Manag Care 2006;12:277-83.
37. Taylor SJ, Milanova T, Hourihan F, et al. A cost-effectiveness analysis of a community pharmacist-initiated disease state management service for type 2 diabetes mellitus. Int J Pharm Pract 2005;13:33-40.
38. Choe HM, Mitrovich S, Dubay D, Hayward RA, Krein SL, Vijan S. Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. Am J Manag Care 2005;11:253-60.
39. Clifford RM, Batty KT, Davis TM, et al. A randomised controlled trial of a pharmaceutical care programme in high-risk diabetic patients in an outpatient clinic. Int J Pharm Pract 2002;10:85-9.
40. Fornos JA, Andres NF, Andres JC, Guerra MM, Egea B. A pharmacotherapy follow-up program in patients with type-2 diabetes in community pharmacies in Spain. Pharm World Sci 2006;28:65-72.
41. Guirguis LM, Johnson JA, Farris KB, Tsuyuki RT, Toth EL. A pilot study to evaluate the role of pharmacists as certified diabetes educators on the clinical and humanistic outcomes of people with diabetes. Can J Diab Care 2001;25:266-76.
42. Jaber LA, Halapy H, Fernet M, Tummalapalli S, Diwakaran H. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother 1996;30:238-43.
43. Odegard PS, Goo A, Hummel J, Williams KL, Gray SL. Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention. Ann Pharmacother 2005;39:433-40.
44. Rothman RL, Malone R, Bryant B, et al. A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes. Am J Med 2005;118:276-84.
45. Scott DM, Boyd ST, Stephan M, Augustine SC, Reardon TP. Outcomes of pharmacist-managed diabetes care services in a community health center. Am J Health-Syst Pharm 2006;63:2116-22.
46. Vivian EM. Improving blood pressure control in a pharmacist-managed hypertension clinic. Pharmacotherapy 2002;22:1533-40.
47. Clifford RM, Davis WA, Batty KT, Davis TM. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle diabetes study. Diabetes Care 2005;28:771-6.
48. Armour CL, Taylor SJ, Hourihan F, Smith C, Krass I. Implementation and evaluation of Australian pharmacists' diabetes care services. J Am Pharm Assoc 2004;44:455-66.
49. Davidson MB, Karlan VJ, Hair TL. Effect of a pharmacist-managed diabetes care program in a free medical clinic. Am J Med Qual 2000;15:137-42.
50. Gong C, Hasson NK, Lum BL. Impact of a diabetes disease management clinic on the total glycosylated hemoglobin of patients with type 2 diabetes mellitus. J Manag Care Pharm 1999;5:511-15.
51. Hogan EG, Leal S, Slack M, Apgar D. Comparison of pharmacist led collaborative drug therapy management to standard physician provided therapy for type 2 diabetes mellitus. Presented at the midyear clinical meeting of the American Society of Health-System Pharmacists, Las Vegas, Nevada, December 4-8, 2005.
52. Irons BK, Lenz RJ, Anderson SL, Wharton BL, Habeger B, Anderson HG Jr. A retrospective cohort analysis of the clinical effectiveness of a physician-pharmacist collaborative drug therapy management diabetes clinic. Pharmacotherapy 2002;22:1294-300.
53. Kelly C, Rodgers P. Implementation and evaluation of a pharmacist-managed diabetes service. J Manag Care Pharm 2000;6:488-93.
54. Krass I, Armour CL, Mitchell B, et al. The pharmacy diabetes care program: assessment of a community pharmacy diabetes service model in Australia. Diabet Med 2007;24:677-83.
55. Krass I, Taylor SJ, McInman A, Armour CL. The pharmacist's role in continuity of care in type 2 diabetes: an evaluation of a model. J Pharm Technol 2006;22:3-8.
56. Leung WY, So WY, Tong PC, Chan NN, Chan JC. Effects of structured care by a pharmacist-diabetes specialist team in patients with type 2 diabetic nephropathy [online exclusive article]. Am J Med 2005;118:1414.e21-7. Available from http://dx.doi.org/10.1016/j.amjmed.2005.07.050.
57. Martin OJ, Wu WC, Schleinitz MD, et al. Effectiveness of pharmacist-coordinated care to reduce cardiovascular risk factors in patients with diabetes mellitus [online exclusive abstract]. Circulation 2004;109:e121. Available from http://circ.ahajournals.org/cgi/reprint/109/7/e71.pdf.
58. Shane-McWhorter L, Oderda GM. Providing diabetes education and care to underserved patients in a collaborative practice at a Utah community health center. Pharmacotherapy 2005;25:96-109.
59. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003;348:383-93.
60. Cranor CW, Christensen DB. The Asheville project: factors associated with outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash) 2003;43:160-72.
61. Cranor CW, Christensen DB. The Asheville project: short-term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash) 2003;43:149-59.
62. Chabot I, Moisan J, Gregoire JP, Milot A. Pharmacist intervention program for control of hypertension. Ann Pharmacother 2003;37:1186-93.
63. Von Muenster SJ, Carter BL, Weber CA, et al. Description of pharmacist interventions during physician-pharmacist co-management of hypertension [published online ahead of print August 21, 2007]. Pharm World Sci 2008;30:128-35. Available from http://dx.doi.org/10.1007/s11096-007-9155-6.
64. Zillich AJ, Sutherland JM, Kumbera PA, Carter BL. Hypertension outcomes through blood pressure monitoring and evaluation by pharmacists (HOME study). J Gen Intern Med 2005;20:1091-6.
65. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
66. United Kingdom Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
67. Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-53.